Sign in
4

Changes in Ownership

Regencell Bioscience Holdings Ltd Filed Acc 0001213900-26-121409

Director acquired 36,001 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LO WILLIAM WING YAN DR · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-17 Exercise or conversion : show line 1 in the form +36,001 $0.84 $30,241 485,629 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2026-11-17 Exercise or conversion : show line 2 in the form Stock option (right to purchase) −36,001 $0.84 2033-01-01 36,001 485,629 D
Loading xslF345X06/ownership.xml…